MedTrace Logo

Lancing Device Comparison Study

NCT01740778 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2012-12-04

No results posted yet for this study

Summary

To evaluate pain responses using the Aurora lancing device and Velvet 33g lancet compared to other common, commercially available lancing systems. Subjects will test the devices at a depth setting sufficient to provide enough blood volume to trigger the OneTouch® Ultra®Mini blood glucose meter using OneTouch® Ultra® blood glucose test strips from either the fingertip or alternate site testing.

Conditions

  • Diabetes Mellitus, Type 1
  • Diabetes Mellitus, Type 2

Sponsors & Collaborators

  • Facet Technologies

    lead OTHER

Principal Investigators

  • Ashley Shemain, MBA · SHEMAIN CONSULTING GROUP, LLC

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2009-09-30
Completion
2009-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01740778 on ClinicalTrials.gov